Cargando…

Effects of percutaneous angioplasty on kidney function and blood pressure in patients with atherosclerotic renal artery stenosis

BACKGROUND: Previous randomized controlled trials of revascularization for atherosclerotic renal artery stenosis (ARAS) were not successful. We investigated the effects of percutaneous transluminal angioplasty with stent insertion (PTA/S) on kidney function and blood pressure (BP) control in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Suhyun, Kim, Mi Jeoung, Jeon, Jeunseok, Jang, Hye Ryoun, Park, Kwang Bo, Huh, Wooseong, Do, Young Soo, Kim, Yoon-Goo, Kim, Dae Joong, Oh, Ha Young, Lee, Jung Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Nephrology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727892/
https://www.ncbi.nlm.nih.gov/pubmed/31234613
http://dx.doi.org/10.23876/j.krcp.18.0148
_version_ 1783449340453322752
author Kim, Suhyun
Kim, Mi Jeoung
Jeon, Jeunseok
Jang, Hye Ryoun
Park, Kwang Bo
Huh, Wooseong
Do, Young Soo
Kim, Yoon-Goo
Kim, Dae Joong
Oh, Ha Young
Lee, Jung Eun
author_facet Kim, Suhyun
Kim, Mi Jeoung
Jeon, Jeunseok
Jang, Hye Ryoun
Park, Kwang Bo
Huh, Wooseong
Do, Young Soo
Kim, Yoon-Goo
Kim, Dae Joong
Oh, Ha Young
Lee, Jung Eun
author_sort Kim, Suhyun
collection PubMed
description BACKGROUND: Previous randomized controlled trials of revascularization for atherosclerotic renal artery stenosis (ARAS) were not successful. We investigated the effects of percutaneous transluminal angioplasty with stent insertion (PTA/S) on kidney function and blood pressure (BP) control in patients with ARAS. METHODS: From 2000 to 2017, 47 subjects who underwent PTA/S for ARAS were identified. A high-risk group was defined, composed of patients having one or more of the following clinical presentations: pulmonary edema, refractory hypertension, and rapid deterioration of kidney function. Subjects who met the criteria of ‘kidney function improvement’ or ‘hypertension improvement’ after PTA/S were classified as responders. RESULTS: Twenty-one (44.7%) subjects were classified into the high-risk group. Two subjects (8.0%) in the low-risk group (n = 25) and 5 subjects (27.8%) in the high-risk group (n = 18) showed improvement in kidney function after PTA/S (P = 0.110). In patients with rapid decline of kidney function, estimated glomerular filtration rate improved from 28 (interquartile range [IQR], 10–45) mL/min/1.73 m(2) to 41 (IQR, 16–67) mL/min/1.73 m(2) at 4 months after PTA/S, although the difference was not significant (P = 0.084). Regarding BP control, 9 (36.0%) and 14 (77.8%) subjects showed improvement after PTA/S in the low- (n = 25) and high-risk (n = 18) groups, respectively (P = 0.007). In patients with refractory hypertension, the systolic BP dropped from 157 (IQR, 150–164) mmHg to 140 (IQR, 131–148) mmHg at 4 months after PTA/S (P = 0.005). Twenty-five subjects were defined as responders and comprised a significant proportion of the high-risk group (P = 0.004). CONCLUSION: PTA/S might improve BP control and kidney function in patients with ARAS presenting with high-risk clinical features. The optimal application of PTA/S should be based on individual assessment of the clinical significance of renal artery stenosis.
format Online
Article
Text
id pubmed-6727892
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Korean Society of Nephrology
record_format MEDLINE/PubMed
spelling pubmed-67278922019-09-09 Effects of percutaneous angioplasty on kidney function and blood pressure in patients with atherosclerotic renal artery stenosis Kim, Suhyun Kim, Mi Jeoung Jeon, Jeunseok Jang, Hye Ryoun Park, Kwang Bo Huh, Wooseong Do, Young Soo Kim, Yoon-Goo Kim, Dae Joong Oh, Ha Young Lee, Jung Eun Kidney Res Clin Pract Original Article BACKGROUND: Previous randomized controlled trials of revascularization for atherosclerotic renal artery stenosis (ARAS) were not successful. We investigated the effects of percutaneous transluminal angioplasty with stent insertion (PTA/S) on kidney function and blood pressure (BP) control in patients with ARAS. METHODS: From 2000 to 2017, 47 subjects who underwent PTA/S for ARAS were identified. A high-risk group was defined, composed of patients having one or more of the following clinical presentations: pulmonary edema, refractory hypertension, and rapid deterioration of kidney function. Subjects who met the criteria of ‘kidney function improvement’ or ‘hypertension improvement’ after PTA/S were classified as responders. RESULTS: Twenty-one (44.7%) subjects were classified into the high-risk group. Two subjects (8.0%) in the low-risk group (n = 25) and 5 subjects (27.8%) in the high-risk group (n = 18) showed improvement in kidney function after PTA/S (P = 0.110). In patients with rapid decline of kidney function, estimated glomerular filtration rate improved from 28 (interquartile range [IQR], 10–45) mL/min/1.73 m(2) to 41 (IQR, 16–67) mL/min/1.73 m(2) at 4 months after PTA/S, although the difference was not significant (P = 0.084). Regarding BP control, 9 (36.0%) and 14 (77.8%) subjects showed improvement after PTA/S in the low- (n = 25) and high-risk (n = 18) groups, respectively (P = 0.007). In patients with refractory hypertension, the systolic BP dropped from 157 (IQR, 150–164) mmHg to 140 (IQR, 131–148) mmHg at 4 months after PTA/S (P = 0.005). Twenty-five subjects were defined as responders and comprised a significant proportion of the high-risk group (P = 0.004). CONCLUSION: PTA/S might improve BP control and kidney function in patients with ARAS presenting with high-risk clinical features. The optimal application of PTA/S should be based on individual assessment of the clinical significance of renal artery stenosis. Korean Society of Nephrology 2019-09 2019-09-30 /pmc/articles/PMC6727892/ /pubmed/31234613 http://dx.doi.org/10.23876/j.krcp.18.0148 Text en Copyright © 2019 by The Korean Society of Nephrology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kim, Suhyun
Kim, Mi Jeoung
Jeon, Jeunseok
Jang, Hye Ryoun
Park, Kwang Bo
Huh, Wooseong
Do, Young Soo
Kim, Yoon-Goo
Kim, Dae Joong
Oh, Ha Young
Lee, Jung Eun
Effects of percutaneous angioplasty on kidney function and blood pressure in patients with atherosclerotic renal artery stenosis
title Effects of percutaneous angioplasty on kidney function and blood pressure in patients with atherosclerotic renal artery stenosis
title_full Effects of percutaneous angioplasty on kidney function and blood pressure in patients with atherosclerotic renal artery stenosis
title_fullStr Effects of percutaneous angioplasty on kidney function and blood pressure in patients with atherosclerotic renal artery stenosis
title_full_unstemmed Effects of percutaneous angioplasty on kidney function and blood pressure in patients with atherosclerotic renal artery stenosis
title_short Effects of percutaneous angioplasty on kidney function and blood pressure in patients with atherosclerotic renal artery stenosis
title_sort effects of percutaneous angioplasty on kidney function and blood pressure in patients with atherosclerotic renal artery stenosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727892/
https://www.ncbi.nlm.nih.gov/pubmed/31234613
http://dx.doi.org/10.23876/j.krcp.18.0148
work_keys_str_mv AT kimsuhyun effectsofpercutaneousangioplastyonkidneyfunctionandbloodpressureinpatientswithatheroscleroticrenalarterystenosis
AT kimmijeoung effectsofpercutaneousangioplastyonkidneyfunctionandbloodpressureinpatientswithatheroscleroticrenalarterystenosis
AT jeonjeunseok effectsofpercutaneousangioplastyonkidneyfunctionandbloodpressureinpatientswithatheroscleroticrenalarterystenosis
AT janghyeryoun effectsofpercutaneousangioplastyonkidneyfunctionandbloodpressureinpatientswithatheroscleroticrenalarterystenosis
AT parkkwangbo effectsofpercutaneousangioplastyonkidneyfunctionandbloodpressureinpatientswithatheroscleroticrenalarterystenosis
AT huhwooseong effectsofpercutaneousangioplastyonkidneyfunctionandbloodpressureinpatientswithatheroscleroticrenalarterystenosis
AT doyoungsoo effectsofpercutaneousangioplastyonkidneyfunctionandbloodpressureinpatientswithatheroscleroticrenalarterystenosis
AT kimyoongoo effectsofpercutaneousangioplastyonkidneyfunctionandbloodpressureinpatientswithatheroscleroticrenalarterystenosis
AT kimdaejoong effectsofpercutaneousangioplastyonkidneyfunctionandbloodpressureinpatientswithatheroscleroticrenalarterystenosis
AT ohhayoung effectsofpercutaneousangioplastyonkidneyfunctionandbloodpressureinpatientswithatheroscleroticrenalarterystenosis
AT leejungeun effectsofpercutaneousangioplastyonkidneyfunctionandbloodpressureinpatientswithatheroscleroticrenalarterystenosis